Publication | Closed Access

Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial

Relapsing-remitting Multiple SclerosisSimcombin StudyImmunologyClinical TrialsNeurological ProgressNeurologyMultiple SclerosisMedicineNovel TherapyAdd-on Therapy